@article{article, title  = {{Cost-effectiveness (CE) of lapatinib plus capecitabine (L+C) in women with HER2+ metastatic breast cancer (MBC) who received prior therapy with trastuzumab (TZ) based on updated survival data from EGF100151.}},

 url = {{}},

 year = {{2008}},

 month = {{5}},

 author = {{DeLea T and Tappenden P and Sofrygin O and Karnon J and Amonkar M and Browning D and Rudge HJ and Walker MD}},

 volume = {{26}},

 journal = {{J Clin Oncol}},

 issue = {{15_suppl}},

 pages = {{6559}},

 note = {{Accessed on 2024/12/21}}}